ECS, an IT systems integrator focused on data and AI, cybersecurity, and enterprise transformation solutions, and an ASGN (NYSE: ASGN) brand, has been named a prime contractor on the National Institutes of Health National Institute of Allergy and Infectious Diseases Enabling and Advancing Technologies blanket purchase agreement. This five-year, multi-award contract vehicle with the NIH, which represents new work for ECS, positions the company to deliver the entire range of IT support services to the NIAID, including cyber infrastructure, software engineering, cybersecurity, AI, and data management and analytics solutions.
ECS currently performs business operations support and analytical support services for the National Heart, Lung, and Blood Institute and provides cybersecurity services to the NIH Information Security and Assurance Office (ISAO) within the NIH Center for Information Technology (CIT).
The new work, overseen by the NIH NIAID Office of Cyber Infrastructure and Computational Biology, will support the NIAID’s mission of conducting basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. NIAID expects to spend nearly $1.1 billion via this contract vehicle over the next five years.
Said ECS President John Heneghan, “ECS is proud to support NIAID’s efforts to lead the world in scientific research that will improve our understanding, diagnosis, and treatment of infectious, immunologic, and allergic diseases.”
ASGN shares closed Monday at $95.35.
